Drug Approval | March 01, 2023
The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years
Experts’ conclave to pave holistic approach to cancer management
AI-based medical imaging equipment firm Lunit has signed a contract to supply AI-based breast cancer screening solution “Lunit Insight MMG”
Fulvestrant Injection, 250 mg/5 mL, has an estimated market size of US $71 million for twelve months ending Sep 2022 according to IQVIA
The product is backed by required scientific proof and comparative bioequivalence studies
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
Results reinforce commitment to next-generation oral SERD development programme
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
Subscribe To Our Newsletter & Stay Updated
